What does Parabilis Medicines, Inc. do?
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered…
What is Parabilis Medicines, Inc.'s P/E and P/B ratio?
Parabilis Medicines, Inc. has a P/E ratio of -2.8 and a P/B ratio of 3.17.
What is Parabilis Medicines, Inc.'s debt-to-equity ratio?
Parabilis Medicines, Inc. has a debt-to-equity ratio of 0.05.
How much does Parabilis Medicines, Inc. owe compared with what it owns?
Parabilis Medicines, Inc. owes $0.11 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Parabilis Medicines, Inc.'s Positivity rank?
Parabilis Medicines, Inc. is ranked #4,424 of 6,774 companies globally and #2,206 of 4,000 in United States on PositoAI, with a Positivity Score of 19,478.
Does Parabilis Medicines, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Parabilis Medicines, Inc..
Where can I read the latest news about Parabilis Medicines, Inc.?
Recent headlines about Parabilis Medicines, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Parabilis Medicines, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Parabilis Medicines, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.